Affordable Access

[Histoculture drug response assay guided adjuvant chemotherapy in patients with ERCC1-positive non-small cell lung cancer].

Authors
  • Hirai, Yoshimitsu1
  • Yoshimasu, Tatsuya
  • Oura, Shoji
  • Tamaki, Takeshi
  • Ota, Fuminori
  • Nakamura, Rie
  • Shimizu, Yukio
  • Naito, Koma
  • Ota, Megumi
  • Miyasaka, Miwako
  • Okamura, Yoshitaka
  • Nakamura, Yasushi
  • Yasuoka, Hironao
  • Kodama, Rieko
  • 1 Department of Thoracic and Cardiovascular Surgery, Wakayama Medical University.
Type
Published Article
Journal
Gan to kagaku ryoho. Cancer & chemotherapy
Publication Date
Apr 01, 2009
Volume
36
Issue
4
Pages
611–614
Identifiers
PMID: 19381033
Source
Medline
License
Unknown

Abstract

HDRA may provide effective non-platinum adjuvant chemotherapy protocols for patients with ERCC1-positive, i.e. CDDP resistant, NSCLC.

Report this publication

Statistics

Seen <100 times